IMVARIA Announces FDA De Novo Marketing Authorization of Fib

Press Release IMVARIA Inc., a health tech company pioneering AI-driven digital biomarker solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted marketing authorization for the use of Fibresolve, a digital biomarker solution that uses…

Related Keywords

United States , Stanford University , California , Berkeley , Stanford , American , Joshua Mooney , Joshua Reicher , Anthony Petrucci , Michael Muelly , Drug Administration , American Medical Association , Digital Biomarker Lab , Google , Authorized Breakthrough , Fibresolve Breakthrough Device , Clinical Assistant Professor , Critical Care , Stanford Medicine , Multidisciplinary Discussion ,